Clinical Effectiveness and Safety Study of Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI).

Trial Profile

Clinical Effectiveness and Safety Study of Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI).

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2013

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 24 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 24 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top